Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Jounce Therapeutics 10%+ Shareholder Tang Capital Partners Reported Purchase of 85,987 Shares @ Avg Price Of $1.00/Share in Form 4 Filing on Tuesday

Author: Charles Gross | March 15, 2023 03:58am

Posted In: JNCE